Synthego announces CEO Transition for Enabling CRISPR Therapeutics
Leadership change simultaneous to the Eclipse Cell Engineering platform spinout as EditCo Bio Synthego Corporation, a leading provider of genome engineering solutions, announced that Paul Dabrowski will step...
